Fox Business - The Power to Prosper
Search Site

Drug Companies

Cubist Pharmaceuticals a long-term buy?

FBN’s Charles Payne, NewOak Capital President James Frischling, small business expert Susan Solovic, retail analyst Hitha Prabhakar and Penn Financial Group founder Matt McCall on the outlook for Cubist Pharmaceuticals.

Read More

  1. New cancer drug going on sale for $150K a year?

    American Cancer Society’s Dr. Len Lichtenfeld on the pricey new cancer medications going on sale.

  2. Stossel 07/31/14: Let us experiment

    Stossel and his family members talk about out-of-the-ordinary things they've tried

  3. How much of a threat does Ebola pose to U.S.?

    NYU Langone Medical Center’s Dr. Natalie Azar on the Ebola outbreak in Africa.

  4. Global cyber-crime market sized at $104B

    F5 Networks CEO John McAdam explains why company shares are continuing to rise and how the company protects data.

  5. DOJ charges FedEx in prescription drug shipping probe

    Former federal prosecutor Doug Burns on the DOJ’s indictment of FedEx over prescription drug shipments.

  6. Ralph Nader: It’s an institutional cover-up

    ‘Unstoppable’ author Ralph Nader on the mounting General Motors recall scandal.

  7. 14 tech, drug companies parking cash overseas

    FBN’s Liz MacDonald on companies with massive overseas cash piles.

  8. More states ready to approve ‘Right to Try’ bill?

    The Goldwater Institute’s Lucy Caldwell on the ‘Right to Try’ legislation.

  9. Omnicom-Publicis deal collapse: What’s next?

    MDC Partners CEO Miles Nadal on the collapse of the Omnicom-Publicis deal.

  10. Looking at LinkedIn

    Schaefer’s Investment Research senior equity analyst Joe Bell and Bryn Mawr Trust CIO Ernie Cecilia on LinkedIn and other stocks to invest in.

  11. Stossel 03/27/14: Government bullies

    Stossel and guest discuss how government uses its force to push people around and take their stuff

  12. Study reveals antibiotic-resistant Superbug found in homes

    FNC Medical A-Team’s Dr. Marc Siegel on the MRSA Superbug, Ebola and a second wave of the Flu hitting the Northeastern U.S.

  1. Wadhwa on the future of innovation in health care

    Stanford University Fellow Vivek Wadhwa on how the tech industry will impact health care.

  2. Finding the right doctor and hospital for your needs

    HealthGrades.com Strategic Advisor Dr. Archelle Georgiou on helping consumers finding the right doctors and hospitals.

  3. Private hospital or government to blame for Ebola response?

    Black Rock Group Senior Director Lisa Boothe and Newsday columnist Ellis Henican on efforts to contain the Ebola crisis.

  4. Travel bans enough to keep Ebola from the U.S.?

    FBN’s Tom Sullivan and Charlie Gasparino on the threat of Ebola coming to the U.S. and travel bans.

  5. Cost of cancer treatments

    Radiation oncologist Dr. Elizabeth Chabner Thompson on the high price tags in the fight against cancer.

  6. Medivation shares a ‘buy’ despite extreme volatility?

    FBN’s Charles Payne, Lebenthal Asset Management’s James Lebenthal and Penn Financial Group founder Matt McCall on the outlook for Medivation.

  7. Roche breast cancer drug extending lives of patients

    Fox News Medical A-Team's Dr. Marc Siegel discusses a new drug to treat breast cancer.

‹ Prev12345Next ›
Freebase CC-BY
Source: Drug Companies on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL